• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官移植受者鳞状细胞癌管理指南。

Guidelines for the management of squamous cell carcinoma in organ transplant recipients.

作者信息

Stasko Thomas, Brown Marc D, Carucci John A, Euvrard Sylvie, Johnson Timothy M, Sengelmann Roberta D, Stockfleth Eggert, Tope Whitney D

机构信息

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

出版信息

Dermatol Surg. 2004 Apr;30(4 Pt 2):642-50. doi: 10.1111/j.1524-4725.2004.30150.x.

DOI:10.1111/j.1524-4725.2004.30150.x
PMID:15061849
Abstract

BACKGROUND

Solid-organ transplant recipients have a high incidence of cutaneous squamous cell carcinoma (SCC) and often develop multiple and aggressive tumors. There are few published studies or reviews, which provide guidance to the clinician in the treatment of these patients.

OBJECTIVE

The objective was to develop useful clinical guidelines for the treatment of skin cancer in organ transplant recipients (OTRs).

METHODS

The members of the Guidelines Committee of the International Transplant-Skin Cancer Collaborative (ITSCC) carried out a computerized search utilizing the databases of the National Library of Medicine for reports in the literature on SCC in OTRs. These reports were collectively examined by the group and combined with experiences from the members' clinical practices in the development of the guidelines.

RESULTS

More than 300 articles relating to SCC in OTRs were reviewed. In general, reports concerning the prevention and treatment of SCC in OTRs are of individual cases or small case series. They are retrospective in nature, statistically nonrigorous, and lack the complete epidemiologic data necessary to derive definitive conclusions. Combining these studies and collective clinical experience, however, is at present the best available method for devising guidelines for the treatment of SCC in OTRs.

CONCLUSION

Guidelines developed for the treatment of skin cancer in OTRs, supported by the best available data and collective clinical experience, may assist in the management of OTRs with SCC. The development of clinical pathways and complete documentation with rigorous prospective study is necessary to improve and refine future guideline development.

摘要

背景

实体器官移植受者皮肤鳞状细胞癌(SCC)的发病率很高,且常发生多发性侵袭性肿瘤。鲜有已发表的研究或综述为临床医生治疗这些患者提供指导。

目的

制定针对器官移植受者(OTR)皮肤癌治疗的实用临床指南。

方法

国际移植-皮肤癌协作组(ITSCC)指南委员会成员利用美国国立医学图书馆数据库对文献中有关OTR的SCC报告进行了计算机检索。该小组对这些报告进行了综合审查,并结合成员临床实践经验制定指南。

结果

共检索并审查了300多篇与OTR的SCC相关的文章。总体而言,关于OTR的SCC预防和治疗的报告多为个案或小病例系列。这些报告本质上是回顾性的,统计学上不严谨,且缺乏得出明确结论所需的完整流行病学数据。然而,将这些研究与集体临床经验相结合,是目前为OTR的SCC制定治疗指南的最佳可用方法。

结论

基于现有最佳数据和集体临床经验制定的OTR皮肤癌治疗指南,可能有助于管理患有SCC的OTR。有必要制定临床路径并通过严格的前瞻性研究进行完整记录,以改进和完善未来的指南制定。

相似文献

1
Guidelines for the management of squamous cell carcinoma in organ transplant recipients.器官移植受者鳞状细胞癌管理指南。
Dermatol Surg. 2004 Apr;30(4 Pt 2):642-50. doi: 10.1111/j.1524-4725.2004.30150.x.
2
Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.免疫抑制会影响 CD4+mRNA 的表达,并在器官移植受者皮肤鳞状细胞癌的微环境中诱导 Th2 优势。
J Immunother. 2010 Jun;33(5):538-46. doi: 10.1097/CJI.0b013e3181cc2615.
3
Declining incidence of keratinocyte carcinoma in organ transplant recipients.器官移植受者中角质形成细胞癌发病率的下降
Br J Dermatol. 2019 Nov;181(5):983-991. doi: 10.1111/bjd.18094.
4
Systemic strategies for chemoprevention of skin cancers in transplant recipients.移植受者皮肤癌化学预防的全身策略。
Clin Transplant. 2005 Dec;19(6):726-34. doi: 10.1111/j.1399-0012.2005.00412.x.
5
Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.器官移植受者的皮肤鳞状细胞癌:关于肿瘤部位的瑞典队列研究
Arch Dermatol. 2005 Apr;141(4):447-51. doi: 10.1001/archderm.141.4.447.
6
In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.器官移植受者和非免疫抑制患者原发性皮肤鳞状细胞癌的转运途中转移:21例患者的临床特征、治疗及结局
Dermatol Surg. 2004 Apr;30(4 Pt 2):651-5. doi: 10.1111/j.1524-4725.2004.30151.x.
7
[Swiss clinical practice guidelines for skin cancer in organ transplant recipients].[瑞士器官移植受者皮肤癌临床实践指南]
Rev Med Suisse. 2010 Apr 28;6(246):854-9.
8
Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.器官移植受者晚期皮肤鳞状细胞癌治疗中的化疗:理论与实践考量
Dermatol Surg. 2004 Apr;30(4 Pt 2):679-86. doi: 10.1111/j.1524-4725.2004.30156.x.
9
Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.免疫功能低下的实体器官移植受者的非黑素瘤皮肤癌的管理。
Curr Treat Options Oncol. 2012 Sep;13(3):354-76. doi: 10.1007/s11864-012-0195-3.
10
Squamous cell carcinoma in organ transplant recipients: approach to management.器官移植受者的鳞状细胞癌:管理方法
Skin Therapy Lett. 2004 Apr;9(4):5-7.

引用本文的文献

1
Cutaneous squamous cell carcinoma of the scalp surrounding a ventriculoperitoneal shunt in a renal transplant recipient with spina bifida.
JAAD Case Rep. 2025 Jan 9;58:109-114. doi: 10.1016/j.jdcr.2024.12.026. eCollection 2025 Apr.
2
Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.首次移植后皮肤鳞状细胞癌后的干预措施:一个建议的决策框架。
Transpl Int. 2022 Nov 22;35:10880. doi: 10.3389/ti.2022.10880. eCollection 2022.
3
Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.哺乳动物雷帕霉素靶蛋白在皮肤鳞状细胞癌及癌前病变中的表达及意义。
Bioengineered. 2021 Dec;12(2):9930-9938. doi: 10.1080/21655979.2021.1984719.
4
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.基于共识的实体器官移植受者鳞状细胞癌预防推荐意见:德尔菲共识声明。
JAMA Dermatol. 2021 Oct 1;157(10):1219-1226. doi: 10.1001/jamadermatol.2021.3180.
5
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients.接受调查的皮肤科医生治愈实体器官移植受者侵袭性鳞状细胞癌的可能性较小。
Int J Womens Dermatol. 2019 Nov 7;6(2):99-101. doi: 10.1016/j.ijwd.2019.10.005. eCollection 2020 Mar.
6
Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.PI3K/mTOR 驱动的皮肤鳞状细胞癌的阶段依赖性治疗效果。
Cell Death Differ. 2018 Jun;25(6):1146-1159. doi: 10.1038/s41418-017-0032-0. Epub 2017 Dec 13.
7
Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.器官移植受者皮肤鳞状细胞癌的管理和预防中的研究空白。
Br J Dermatol. 2017 Nov;177(5):1225-1233. doi: 10.1111/bjd.15950. Epub 2017 Oct 30.
8
Renal association clinical practice guideline in post-operative care in the kidney transplant recipient.肾脏移植受者术后护理的肾脏协会临床实践指南
BMC Nephrol. 2017 Jun 2;18(1):174. doi: 10.1186/s12882-017-0553-2.
9
Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases.既往肾移植后皮肤鳞状细胞癌患者再次肾移植后侵袭性皮肤癌的风险:一项对53例病例的回顾性研究
Transplantation. 2017 Apr;101(4):e133-e141. doi: 10.1097/TP.0000000000001644.
10
[Cutaneous manifestations in renal diseases].[肾脏疾病中的皮肤表现]
Hautarzt. 2016 Dec;67(12):960-969. doi: 10.1007/s00105-016-3890-3.